Pidotimod
M-PIMOT-40
Approved small_molecule completed
Quick answer
Pidotimod for Recurrent Respiratory Tract Infections is a Approved program (small_molecule) at Almirall, S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Almirall, S.A.
- Indication
- Recurrent Respiratory Tract Infections
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed